BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29969773)

  • 21. Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.
    Yang GP; Yuan H; Tang B; Zhang W; Wang LS; Huang ZJ; Ou-Yang DS; Zhang GX; Zhou HH
    Acta Pharmacol Sin; 2010 Mar; 31(3):382-6. PubMed ID: 20140004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method.
    Yoshida K; Takano J; Ishizu Y; Lezhava A; Ieiri I; Maeda K; Hayashizaki Y; Sugiyama Y
    AAPS J; 2013 Apr; 15(2):618-22. PubMed ID: 23471819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians.
    Sortica VA; Fiegenbaum M; Lima LO; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
    Clin Chem Lab Med; 2012 Mar; 50(3):441-8. PubMed ID: 22505549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.
    Merćep I; Radman I; Trkulja V; Božina T; Šimičević L; Budimir E; Ganoci L; Božina N
    Eur J Clin Pharmacol; 2022 Feb; 78(2):227-236. PubMed ID: 34668025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine.
    Aklillu E; Habtewold A; Ngaimisi E; Yimer G; Mugusi S; Amogne W; Reuter T; Meid A; Hoffmann MM; Weiss J
    OMICS; 2016 Sep; 20(9):538-45. PubMed ID: 27631193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum SLCO1B1 levels and genetic variants of SLCO1B1 rs4149056 and rs2306283 in patients with early and exudative age-related macular degeneration.
    Liutkeviciene R; Vilkeviciute A; Slavinskaite A; Petrauskaite A; Tatarunas V; Kriauciuniene L
    Gene; 2018 Nov; 676():139-145. PubMed ID: 30010042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population.
    Dashti M; Al-Matrouk A; Channanath A; Al-Mulla F; Thanaraj TA
    Sci Rep; 2022 Sep; 12(1):14858. PubMed ID: 36050458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.
    Jiang F; Choi JY; Lee JH; Ryu S; Park ZW; Lee JG; Na HS; Lee SY; Oh WY; Chung MW; Choi SE
    Pharmacogenomics; 2017 Apr; 18(5):459-469. PubMed ID: 28350522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
    Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S
    Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Wagner JB; Abdel-Rahman S; Raghuveer G; Gaedigk A; Boone EC; Gaedigk R; Staggs VS; Reed GA; Zhang N; Leeder JS
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins.
    Dou Y; Zhu X; Wang Q; Tian X; Cheng J; Zhang E
    Ann Lab Med; 2015 May; 35(3):329-35. PubMed ID: 25932441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.
    Santos PC; Soares RA; Nascimento RM; Machado-Coelho GL; Mill JG; Krieger JE; Pereira AC
    BMC Med Genet; 2011 Oct; 12():136. PubMed ID: 21992719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen.
    Marzolini C; Cavassini M; Braun DL; Hachfeld A; Bernasconi E; Calmy A; Schmid P; Battegay M; Elzi L;
    Br J Clin Pharmacol; 2023 Sep; 89(9):2739-2746. PubMed ID: 37101315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
    Lu B; Sun L; Seraydarian M; Hoffmann TJ; Medina MW; Risch N; Iribarren C; Krauss RM; Oni-Orisan A
    Clin Pharmacol Ther; 2021 Sep; 110(3):733-740. PubMed ID: 34114646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia.
    Wu X; Gong C; Weinstock J; Cheng J; Hu S; Venners SA; Hsu YH; Wu S; Zha X; Jiang S; Li Y; Pan F; Xu X
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):240S-247S. PubMed ID: 30336686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients.
    Xu LY; He YJ; Zhang W; Deng S; Li Q; Zhang WX; Liu ZQ; Wang D; Huang YF; Zhou HH; Sun ZQ
    Acta Pharmacol Sin; 2007 Oct; 28(10):1693-7. PubMed ID: 17883959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
    Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in plasma rifampicin concentrations and role of
    Sileshi T; Makonnen E; Telele NF; Barclay V; Zumla A; Aklillu E
    Infect Dis (Lond); 2024 Apr; 56(4):308-319. PubMed ID: 38315168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.
    Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J
    Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global analysis of genetic variation in SLCO1B1.
    Pasanen MK; Neuvonen PJ; Niemi M
    Pharmacogenomics; 2008 Jan; 9(1):19-33. PubMed ID: 18154446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.